|
Title
|
|
|
|
Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Objective: To validate the influence of the Charlson comorbidity index (CCI) in patients with operated primary non-small cell lung cancer. Methods: From January 1996 to December 2001, 205 consecutive resections for non-small cell lung cancer were performed at the Erasmus Medical Center Rotterdam. The patients ranged in age from 29 to 82 years, with a mean age of 64 years. In a retrospective study, each patient was scaled according to the CCI and the complications of surgery were determined. Results: The hospital mortality was 2.4% (5/205). Of the 205 patients 167 (32.7%) experienced minor complications and 32 (15.6%) major complications. In univariate analysis, gender, grades 3-4 of the CCI, any prior tumor treated in the last 5 years and chronic pulmonary disease were significant predictors of adverse outcome. Multivariate analysis showed that only grades 3-4 of the CCI was predictive (odds ratio = 9.8; 95% confidence interval = 2.1-45.9). Although only comorbidity grades 3-4 was a significant predictor, for every increase of the comorbidity grade the relative risk of adverse outcome showed a slight increase. Conclusion: The CCI is strongly correlated with higher risk of surgery in primary non-small cell lung cancer patients and is a better predictor than individual risk factors. (C) 2002 Elsevier Science B.V. All rights reserved. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
European journal of cardiothoracic surgery. - Berlin
|
|
|
Publication
|
|
|
|
Berlin
:
2003
|
|
|
ISSN
|
|
|
|
1010-7940
|
|
|
DOI
|
|
|
|
10.1016/S1010-7940(02)00721-2
|
|
|
Volume/pages
|
|
|
|
23
:1
(2003)
, p. 30-34
|
|
|
ISI
|
|
|
|
000180412100006
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|